beta
IA Trial Radar
O estudo clínico NCT06744491 (NFRF) para Inatividade física, Envelhecimento, Envelhecimento saudável, Growth & Development, Diferenças Sexuais, Anabolic Sensitivity, Protein Metabolism, Atividade física está ainda não recrutando. Consulte a visualização em cartões do Radar de Estudos Clínicos e as ferramentas de descoberta de IA para ver todos os detalhes. Ou pergunte qualquer coisa aqui.
Um estudo corresponde aos critérios do filtro
Visualização em cartões

Oral 'Breath Test' to Measure Anabolic Sensitivity to a Protein Meal Across the Age and Physical Activity Spectrum (NFRF)

Ainda não recrutando
Os detalhes do estudo clínico estão disponíveis principalmente em inglês. No entanto, a IA Trial Radar pode ajudar! Basta clicar em 'Explicar o estudo' para visualizar e discutir as informações do estudo no idioma selecionado.
O estudo clínico NCT06744491 (NFRF) é um ensaio observacional para Inatividade física, Envelhecimento, Envelhecimento saudável, Growth & Development, Diferenças Sexuais, Anabolic Sensitivity, Protein Metabolism, Atividade física. Seu status atual é: ainda não recrutando. O recrutamento está programado para iniciar em 20 de dezembro de 2024, com o objetivo de incluir 80 participantes. Coordenado por a Universidade de Toronto e deve ser concluído em 31 de agosto de 2025. Essas informações foram atualizadas no ClinicalTrials.gov em 20 de dezembro de 2024.
Resumo
The purpose of this study is to determine how anabolic sensitivity, in response to the ingestion of a liquid protein meal, differs across the lifespan, between biological sexes, and with varying physical activity levels.
Descrição detalhada
Skeletal muscle is a dynamic tissue that responds to anabolic (i.e., growth) stimuli such as protein ingestion and exercise. Differences in age and physical activity levels will influence an individual's ability to respond to these anabolic stimuli; this concept is known as anabolic sensitivity. For instance, older and less physically active individuals will display lower anabolic sensitivity (i.e., anabolic resistance) to a bout of exercise or the consumption of protein in comparison to younger, more physically active individuals. Seeing that individuals with anabolic resistance are at a greater risk for losing muscle mass over time, it is important to understand the anabolic sensitivity/resistance of an individual to assess for the efficiency of growth across the health and lifespan, in addition to a potential screen for metabolic alterations that could manifest into changes in lean body and muscle mass.

Traditional methods to assess for skeletal muscle anabolism and protein metabolism requires in-person and invasive research methods (i.e., stable isotope infusions and muscle biopsies) in controlled laboratory or clinical settings. However, there are many risks associated with these invasive procedures and they are not always feasible in all populations (e.g., children, clinical populations, etc..). Our lab has recently developed a non-invasive 13C breath test which employs an oral stable isotope tracer. Our breath test allows us to assess for anabolic sensitivity in response to protein ingestion, by determining how much of the ingested protein was used to build (synthesize) new proteins in our body (i.e., anabolism) or used as a source of energy (through a process called oxidation). As such, the purpose of the present study is to determine how anabolic sensitivity, in response to the ingestion of a liquid protein meal, differs across the lifespan and with varying physical activity levels.

Título oficial

Anabolic Sensitivity Across the Lifespan

Condições
Inatividade físicaEnvelhecimentoEnvelhecimento saudávelGrowth & DevelopmentDiferenças SexuaisAnabolic SensitivityProtein MetabolismAtividade física
Outros IDs do estudo
  • NFRF
  • 00044004
Número NCT
Data de início (real)
2024-12-20
Última atualização postada
2024-12-20
Data de conclusão (estimada)
2025-08-31
Inscrição (estimada)
80
Tipo de estudo
Observacional
Status
Ainda não recrutando
Palavras-chave
anabolic sensitivity
aging
growth and development
physical activity
skeletal muscle
stable isotopes
Braços / Intervenções
Grupo de participantes/BraçoIntervenção/Tratamento
Children
Children as defined by maturity offset via age from peak height velocity (aPHV \< -1.0 years).
N/A
Adolescent
Adolescents as defined by maturity offset via age from peak height velocity (aPHV -0.5 to +1.5 years)
N/A
Young Adults
Young adults as defined by chronological age between ages 18 - 35 years
N/A
Older Adults
Older adults as defined by chronological age between ages 60 - 80 years
N/A
Desfecho primário
Medida de desfechoDescrição da medidaPrazo
Amino acid oxidation and net protein balance
Amino acid oxidation and net protein balance assessed by oral 1-13C Leucine tracer. Net protein balance is derived from the difference between amino acid intake (known) and total amino acid oxidation over the 6h post-prandial measurement period.
6 Hours
Critérios de elegibilidade

Idades elegíveis
Criança, Adulto, Adulto mais velho
Idade mínima
8 Years
Sexos elegíveis
Todos
Aceita voluntários saudáveis
Sim
  • Healthy will be defined as screened by the PAR-Q+ (The Physical Activity Readiness Questionnaire for everyone)
  • Chronological age for Healthy Young (age: 18-35 years) or Older (age: 60-80 years) adults
  • Chronological age between 8 to 16 years, with maturity offset < -1 year from age of Peak Height Velocity (aPHV) for children and between -0.5 to +1.5 years from aPHV in adolescent participants
  • BMI between normal to overweight (18.5 - 29.9 kg/m2)

  • Regular use of nonsteroidal anti-inflammatory dugs (with the exception of daily low-dose aspirin)
  • use of anticoagulants
  • use of a walker, cane, or assistive walking device
  • infectious or gastrointestinal disease
  • inability to comply with study protocol (e.g., unable to track diet)
  • regular tobacco use
  • self-reported illicit drug use (e.g., growth hormone, testosterone, etc.)
  • diagnosed chronic illness (e.g., type 2 diabetes, heart disease, thyroid disease)
  • pregnant
  • hormonal replacement therapy
Responsável pelo estudo
Daniel Moore, Investigador principal, Professor, Muscle Physiology, University of Toronto
Contato central do estudo
Contato: Daniel R Moore, PhD, 4169464088, [email protected]
Contato: Hugo JW Fung, PhD Candidate, [email protected]
1 Locais do estudo em 1 países

Ontario

Goldring Center for High Performance Sport, Toronto, Ontario, M5S 2C9, Canada
Hugo JW Fung, PhD Candidate, Contato, 416-946-5620, [email protected]